Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models
Alzheimer's disease (AD) afflicts millions of people worldwide and is caused by accumulated amyloid beta and tau pathology. Progression of tau pathology in AD may utilize prion mechanisms of propagation in which pathological tau aggregates released from one cell are taken up by neighboring or c...
Main Authors: | Sourav Kolay, Marc I. Diamond |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.12928 |
Similar Items
-
Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01) -
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
by: Zhiva Skachokova, et al.
Published: (2019-05-01) -
Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
by: Rebecca M. Fleeman, et al.
Published: (2021-03-01) -
Alzheimer’s disease brain contains tau fractions with differential prion-like activities
by: Longfei Li, et al.
Published: (2021-02-01) -
Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
by: Sarah L. DeVos, et al.
Published: (2018-04-01)